Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,100 | -3,455 | -3,619 | 2,932 | -3,562 |
| Depreciation Amortization | 1,078 | 706 | 346 | 1,304 | 970 |
| Income taxes - deferred | 177 | 118 | -113 | 236 | 236 |
| Accounts receivable | -11,768 | -6,919 | -2,275 | 2,317 | 3,069 |
| Other Working Capital | -15,875 | -8,739 | -1,840 | 793 | 4,258 |
| Other Operating Activity | 13,465 | 7,998 | 2,443 | 1,092 | -288 |
| Operating Cash Flow | $-14,023 | $-10,291 | $-5,058 | $8,674 | $4,683 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 20,420 | 20,420 |
| PPE Investments | -1,235 | -737 | -306 | -1,279 | -854 |
| Purchase Of Investment | N/A | N/A | N/A | -15,000 | N/A |
| Other Investing Activity | -19 | -13 | -6 | 80 | -25 |
| Investing Cash Flow | $-1,254 | $-750 | $-312 | $4,221 | $19,541 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -20,420 | -20,420 |
| Common Stock Issued | 9,180 | 9,180 | 5,076 | 3,626 | N/A |
| Financing Cash Flow | $9,180 | $9,180 | $5,076 | $-16,794 | $-20,420 |
| Exchange Rate Effect | -16 | -4 | -8 | 25 | -29 |
| Beginning Cash Position | 19,760 | 19,760 | 19,760 | 23,634 | 23,634 |
| End Cash Position | 13,647 | 17,895 | 19,458 | 19,760 | 27,409 |
| Net Cash Flow | $-6,113 | $-1,865 | $-302 | $-3,874 | $3,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,023 | -10,291 | -5,058 | 8,674 | 4,683 |
| Capital Expenditure | -1,235 | -737 | -306 | -1,282 | -857 |
| Free Cash Flow | -15,258 | -11,028 | -5,364 | 7,392 | 3,826 |